About: Pravastatin Therapy and the Risk of Stroke

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pravastatin Therapy and the Risk of Stroke Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2000 (uk) im August 2000 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q57274395-8859FF12-D17D-4977-A5BF-1A76286D4998
publication date	2000-08-03 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57274395-69AAD066-789C-42EF-BEE0-C0651F687FCE
language of work or name	English
author name string	wds:Q57274395-4FC64DB1-7E23-48AE-9160-6B6F88936A86 wds:Q57274395-6AF750BD-A8C6-44E2-8B9B-ABA02EEBFDDC wds:Q57274395-80F8873C-468B-4BB0-AD0D-790937F5F842 wds:Q57274395-8F16406A-EA21-4198-8A7D-7E23EEB907A3 wds:Q57274395-8F676800-4A13-4A9A-87EB-440E32FA6D8E wds:Q57274395-95D5A5ED-504B-4A9B-9207-B3B96ADC80E9 wds:Q57274395-B187F656-9A6F-46F4-87A1-3EAC127CF29D
author name string	David Hunt Stephen MacMahon R. John Simes David M. Colquhoun Adrienne C. Kirby Malcolm J. West Neil E. Anderson
rdfs:label	Pravastatin Therapy and the Risk of Stroke (en) Pravastatin Therapy and the Risk of Stroke (nl)
skos:prefLabel	Pravastatin Therapy and the Risk of Stroke (en) Pravastatin Therapy and the Risk of Stroke (nl)
name	Pravastatin Therapy and the Risk of Stroke (en) Pravastatin Therapy and the Risk of Stroke (nl)
author	wds:Q57274395-16B098E9-A782-4932-A668-F86D60BABA12 wds:Q57274395-2E73AAB0-D240-4B13-BA18-7E0799F3D65E wds:Q57274395-6E0E1CD5-57B7-4D1B-A2A3-7351AC549380 wds:Q57274395-913A4F51-8FDC-4312-8B53-EEB85A34117F wds:Q57274395-F7F4D7B4-9A3B-43BD-B256-6C4E31EC27B1
author	Paul P. Glasziou Harvey D. White Andrew Tonkin Graeme J. Hankey John D. G. Watson
title	wds:Q57274395-56A5AB59-0375-461B-B132-68D4BF5BE631
title	Pravastatin Therapy and the Risk of Stroke (en)
page(s)	wds:Q57274395-1589F210-7B3C-452B-8C3E-C0F1444B37E2
page(s)	317-326
instance of	wds:Q57274395-1A827F31-21D3-41BC-A08B-69ACD2027459
instance of	scholarly article
PubMed ID	wds:Q57274395-9BB082AF-8714-48B2-A67C-09B79A9BA2FB
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10922421
PubMed ID	10922421
published in	wds:Q57274395-0DB67914-66DA-4F81-9342-A27D3FB4673C
published in	The New England Journal of Medicine
issue	wds:Q57274395-2007273F-55E9-4CE8-BD56-16793433222D
volume	wds:Q57274395-32B1EF96-BCC4-4A5E-A465-CADAB82F8005
issue	5
volume	343
DOI	wds:Q57274395-56255780-F150-4A68-9BCE-77A5CDE8EDBA
DOI	http://dx.doi.org/10.1056/NEJM200008033430502
DOI	10.1056/NEJM200008033430502
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57274395
is cites work of	A benefit-risk assessment of agents used in the secondary prevention of stroke Study of Heart and Renal Protection (SHARP) Statin use and risk of prostate cancer: results from a population-based epidemiologic study Antithrombotic Secondary Prevention After Stroke. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis Prevention of stroke and dementia with statins: Effects beyond lipid lowering Interventions in the management of serum lipids for preventing stroke recurrence All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT. Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study Statins for the prevention of stroke: a meta-analysis of randomized controlled trials Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up Management of dyslipidemia in elderly diabetic patients. Stroke prevention, blood cholesterol, and statins Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque Lipid levels and the risk of ischemic stroke in women. Lipid management in the prevention of stroke: a meta-analysis of fibrates for stroke prevention MicroRNA in ischemic stroke etiology and pathology Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts Potential nontraditional applications of statins Screening and treating adults for lipid disorders. The pleiotropic effects of HMG-CoA reductase inhibitors: their role in osteoporosis and dementia The association between serum adhesion molecules and outcome in acute spontaneous intracerebral hemorrhage. Recent Advances in Stem Cell-Based Therapeutics for Stroke A pravastatin dose-escalation study in systemic lupus erythematosus Histopathology of carotid atherosclerotic disease Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease Strategies to increase HMG-CoA reductase inhibitor use after acute myocardial infarction Progress in the identification of stroke-related genes: emerging new possibilities to develop concepts in stroke therapy Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS) Overcoming 'ageism' bias in the treatment of hypercholesterolaemia : a review of safety issues with statins in the elderly Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstacles Stroke prevention with lipid-lowering therapy Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS). Secondary prevention of stroke: a practical guide to drug treatment Low total cholesterol level is the independent predictor of poor outcomes in patients with acute ischemic stroke: a hospital-based prospective study The role of cholesterol and statins in stroke

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software